EWA
RXDX

EverSource Wealth Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

EverSource Wealth Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$1.07K – 2649
2023
Q1 		$1.07K Buy
+10
New +$1.07K ﹤0.01% 2095